Alpha Tau Medical (NASDAQ:DRTSW) Stock Price Down 7.4% – Should You Sell?

by · The Cerbat Gem

Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report)’s share price dropped 7.4% during trading on Wednesday . The company traded as low as $0.19 and last traded at $0.22. Approximately 103,096 shares were traded during trading, an increase of 412% from the average daily volume of 20,150 shares. The stock had previously closed at $0.24.

Alpha Tau Medical Trading Down 15.0 %

The business has a 50-day simple moving average of $0.28 and a two-hundred day simple moving average of $0.24.

About Alpha Tau Medical

(Get Free Report)

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.

Featured Stories